BEARINGPOINT//BEYOND
12.2.2020 09:02:05 CET | Business Wire | Press release
BearingPoint//Beyond today launched new research that suggests communications service providers (CSPs) are failing to develop the business-to-business (B2B) solutions that are critical to the commercial success of 5G. The study also finds that businesses around the world are more ambitious about the role CSPs will play in 5G than CSPs are themselves.
5G is the first generation of mobile technology that will have a bigger impact on businesses than on consumers1 . On average across Europe, Asia and North America, CSPs anticipate a 15% increase in current revenues from B2B 5G services (significant in an industry struggling with sub-2%2 compound annual revenue growth). 75% of enterprises and small to medium businesses (SMBs) believe 5G will be important to their business citing speed, reliability and more advanced solutions as key reasons.
Growing disconnect
“Businesses want to buy 5G, CSPs want to sell 5G. The problem is that CSPs want to just sell connectivity and standardized ‘connectivity plus infrastructure’ products, while businesses want to buy more sophisticated, complete solutions that better fit their needs and require the integration of multiple technologies from multiple players,” says Angus Ward, CEO, BearingPoint//Beyond.
CSPs must look to broaden their role from communications to providing the broader technologies that support business customers. They need to collaborate with customers to co-innovate and co-create more compelling and sophisticated solutions with a wide range of ecosystem partners, including OTTs, web-scale companies, vertical specialists, even competitors, to meet the demands of business customers.
“CSPs must learn the art of ecosystem orchestration if they want to monetize 5G at scale,” cautions Ward. “Businesses don’t want to build these solutions themselves. And while the vast majority would happily work with CSPs, they’re not waiting around - businesses are already partnering with other companies to solve their business problems. They must move quickly.”
Regional insights & actions
Europe:
- CSPs are pinning their 5G hopes on 4G business models - consumer services and enterprise connectivity. Just a third of CSPs believe their role will extend beyond simple connectivity plus infrastructure offerings. Only 10% of European CSPs believe they will become ecosystem orchestrators.
- 92% of European businesses believe CSPs have a bigger role to play than just providing communications and connectivity. Almost seven in 10 want CSPs to offer 5G solutions that combine their assets with those of partners.
- Enterprises want to work with CSPs to develop 5G solutions because they can orchestrate ecosystems, manage complex programs and understand 5G technology.
“European CSPs must re-engineer their mindsets, and businesses, to capitalize on this opportunity,” says Ward.
North America:
- Confidence and ambition are highest amongst North American CSPs.
- More than three quarters of CSPs agree that creating vertical specific solutions using ecosystems of partners represents a big 5G opportunity. 40% expect to become ecosystem orchestrators.
- North American businesses agree: 96% believe CSPs have a bigger role to play – citing ecosystem orchestration, complex program management and flexibility as reasons they want to work with CSPs to develop 5G use cases.
“North American CSPs now need to act fast, building the right partnerships and the right IT platform to enable them to operate an ecosystem required to meet the expectations of their business customers,” recommends Ward.
Asia:
- More attention is being paid to 5G connectivity-driven models than higher value solutions by Asian CSPs. Just 17% see themselves as ecosystem orchestrators.
- Yet 94% of Asian businesses believe that CSPs can do more than provide communications and connectivity – nearly seven in 10 think CSPs should offer sophisticated services using an ecosystem of partners.
- Again, ecosystem orchestration, complex program management and their knowledge of 5G make CSPs attractive partners for Asian businesses.
“Enterprises and SMBs alike are practically crying out to work with CSPs on 5G solutions - Asian CSPs must heed this call, shake off their doubts and act quickly,” advises Ward.
The time is NOW
“In 5G B2B terms, CSPs are pushing at an open door. 98% of European businesses, 92% of Asian businesses and 87% of North American businesses are willing to buy advanced solutions from their CSP. But these must be solutions that address their specific business needs. The only way CSPs can achieve this is orchestrate ecosystems of partners to co-create compelling new solutions that embed 5G,” continues Ward.
“If CSPs continue to define their role too narrowly, they will miss out entirely on the high margin opportunities in B2B 5G. Connectivity represents a tiny portion - as low as 5% - of the revenue for each use case. By not taking a lead now, CSPs are gifting the majority of 5G revenues to a new generation of OTTs. The much higher cost of 5G networks means they are seriously jeopardising the ability to monetize their 5G investments. CSPs must quickly master the art of ecosystem orchestration if they want to monetize 5G at scale. If they don’t, technology providers and vertical solution providers will. In Asia, CSPs are already seen as ‘second choice’ partners for businesses building 5G use cases, in North America CSPs rank third, in Europe, fourth. CSPs have to demonstrate ambition and make up ground quickly. Inaction will cost CSPs billions of dollars,” concludes Ward.
To download a free copy of ‘If B2B is the ‘North Star’ for 5G revenues: how do CSPs get there?’, please visit https://www.bearingpointbeyond.com/en/industries/5g/5g-b2b/ .
- ENDS -
Methodology
BearingPoint//Beyond commissioned a large-scale primary research study to examine the real attitudes of both CSPs and business customers towards 5G, and the potential role of CSPs in the 5G era. Conducted and analyzed in late-2019, research firm Coleman Parkes interviewed 250 technology decision makers from 100 enterprises and 150 SMBs - in verticals such as manufacturing, financial services, retail, health, education, transportation and media - across Europe, Asia and North America. 90 senior executives within CSPs were also surveyed from these three regions.
At Mobile World Congress 2020
Angus Ward will be speaking on: “A Next-Gen Network demands a Next-Gen Organization”, Tuesday, 25th February: 3:15pm – Hall 4, Auditorium 5. BearingPoint//Beyond’s Head of Marketing, Michal Harris, will be speaking on “Unlocking the Value of Partner Ecosystems”, Monday, 24th February: 3:45pm – Hall 4, Auditorium 4.
About BearingPoint//Beyond
BearingPoint//Beyond is a rapidly growing SaaS-based BSS and digital platform solution provider helping organizations to reinvent their business model and grow revenue by utilizing digital platforms and partner ecosystems.
Our digital platform solutions are designed to help businesses experiment, launch and monetize new offerings at speed, with minimum risk and cost; building connections between technologies and partners, enabling them to collaborate, co-innovate and expand reach with an ecosystem of partners while taking advantage of new technologies such as cloud, IoT AI, 5G and more. This brings organizations closer to their customers, helping drive higher efficiency and automation, to become more agile in the face of competition. BearingPoint//Beyond is owned by BearingPoint.
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: The first unit covers the advisory business with a clear focus on five key areas to drive growth across all regions. The second unit provides IP-driven managed services beyond SaaS and offers business critical services to its clients supporting their business success. The third unit provides the software for successful digital transformation and regulatory requirements. It is also designed to explore innovative business models with clients and partners by driving the financing and development of start-ups and leveraging ecosystems.
BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 75 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
BearingPoint//Beyond home page: https://www.bearingpointbeyond.com
Homepage: www.bearingpoint.com
Annual Report: www.bearingpoint.com/en/about-us/annual-report/
LinkedIn: http://www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
1
GSMA Intelligence, “The 5G era report”, 2017
2
Ovum, “Mobile Subscription and Revenue Forecast Report: 2019-24”
View source version on businesswire.com: https://www.businesswire.com/news/home/20200212005026/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
